Homozygous PGAP2 mutation cause hyperphosphatasia with mental retardation syndrome-3 (HPMRS3): Genetic and clinical evaluation of the ultra rare inherited glycosylphosphatidylinositol (GPI) biosynthesis defect

Homozygous PGAP2 mutations in the patient we reported in our study resulted in a severe clinical picture including severe developmental delay and intellectual disability, severe epilepsy, dysmorphic features, central fever, biochemical, hormonal, and immunological abnormalities. This patient would be the youngest case published in the literature. We showed that the instability of mutant PGAP2 protein that causes hyperphosphatasia with mental retardation syndrome-3 leads to more severe phenotypes.

Authors

Institutions

Publication Details

Journal
Molecular Syndromology
Published
2024-11-26
DOI
https://doi.org/10.1159/000542617
Citations
1
Primary Topic
Studies on Chitinases and Chitosanases
Type
article
Field-Weighted Citation Impact
0.23
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Homozygous PGAP2 mutation cause hyperphosphatasia with mental retardation syndrome-3 (HPMRS3): Genetic and clinical evaluation of the ultra rare inherited glycosylphosphatidylinositol (GPI) biosynthesis defect

Betül Karaatmaca, Berrak Bilginer Gürbüz, Çiğdem Seher Kasapkara, Sümeyra Zeynep Özbey et al.
1 citations
Molecular Syndromology
Studies on Chitinases and Chitosanases
0.23
article

Homozygous PGAP2 mutation cause hyperphosphatasia with mental retardation syndrome-3 (HPMRS3): Genetic and clinical evaluation of the ultra rare inherited glycosylphosphatidylinositol (GPI) biosynthesis defect

Betül Karaatmaca, Berrak Bilginer Gürbüz, Çiğdem Seher Kasapkara, Sümeyra Zeynep Özbey, Aynur Küçükçongar Yavaş, Bora Ergin, Hamìt Özyürek, Ofcan Oflaz, Hacer Basan, Yasemin Ünal
article en
1 citations

Abstract

Homozygous PGAP2 mutations in the patient we reported in our study resulted in a severe clinical picture including severe developmental delay and intellectual disability, severe epilepsy, dysmorphic features, central fever, biochemical, hormonal, and immunological abnormalities. This patient would be the youngest case published in the literature. We showed that the instability of mutant PGAP2 protein that causes hyperphosphatasia with mental retardation syndrome-3 leads to more severe phenotypes.

Molecular SyndromologyVol. 16(5)
Bilkent University (TR), Memorial Ankara Hospital (TR), Başkent University Hospital (TR), Lokman Hekim Üniversitesi (TR), Intergen (Turkey) (TR), Ankara Bilkent City Hospital (TR)
Good health and well-being
Openalex Percentile: Top 41%
Studies on Chitinases and Chitosanases
0.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Homozygous PGAP2 mutation cause hyperphosphatasia with mental retardation syndrome-3 (HPMRS3): Genetic and clinical evaluation of the ultra rare inherited glycosylphosphatidylinositol (GPI) biosynthesis defect — Betül Karaatmaca, Berrak Bilginer Gürbüz, et al. · Molecular Syndromology (2024) | TGRS Research Map | TGRS